FDA panel expected to vote on a third Pfizer COVID-19 shot ahead of White House deadline
A Food and Drug Administration advisory committee is expected to vote on the safety and efficacy of a third dose of the Pfizer-BioNTech vaccine. CBS News' Natalie Brand reports on the debate over whether vaccinated Americans need booster shots, and CBS News researcher Max Bayer has more on the FDA hearing.